Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection.
In murine schistosomiasis, granulomas form around ova deposited in the liver and intestines of infected mice. The granulomas have eosinophils that produce vasoactive intestinal peptide (VIP) and T cells that display VIP receptors. IL-5 is a lymphokine important for the development and maturation of eosinophils. It seemed plausible that VIP, released from eosinophils, may interact with lymphocyte VIP receptors and modulate IL-5 production as part of a feedback regulatory circuit. Thus, we determined whether granuloma T cells make IL-5 and whether VIP modulates IL-5 production. Isolated granuloma cells enriched for T lymphocytes spontaneously released IL-5. Culture of these cells in the presence of VIP increased IL-5 secretion. Spleen cells were also studied. Spleen cells from infected mice did not spontaneously release IL-5 or express IL-5 mRNA and VIP did not stimulate these resting spleen cells to produce this IL. However, these cells did express IL-5 mRNA and secreted IL-5 in response to Con A or soluble egg Ag. VIP could not appreciably modulate IL-5 release when cells were cultured with VIP and the Ag or mitogen. Spleen cells washed free of Con A ceased IL-5 secretion within 24 h. These preactivated splenic T cells resumed vigorous IL-5 secretion in response to either Con A or VIP. Yet only Con A prominently induced IL-5 mRNA expression. VIP was an effective stimulus at concentrations equal to or above the kDa of the VIP receptor on both splenic and granuloma T cells (10(-8) M). It is concluded that, in murine schistosomiasis, VIP invokes IL-5 release from activated T cells that are not undergoing immediate TCR stimulation.
Mathew
R C
RC
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.
Cook
G A
GA
Blum
A M
AM
Metwali
A
A
Felman
R
R
Weinstock
J V
JV
D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology; D003208:Concanavalin A / Q000494:pharmacology; D004804:Eosinophils / Q000378:metabolism; D005260:Female; D015870:Gene Expression; D006099:Granuloma / Q000276:immunology; D015848:Interleukin-5 / Q000378:metabolism*; D008213:Lymphocyte Activation; D051379:Mice; D008808:Mice, Inbred CBA; D012333:RNA, Messenger / Q000235:genetics; D012555:Schistosomiasis mansoni / Q000276:immunology*; D013154:Spleen / Q000503:physiopathology; D013601:T-Lymphocytes / Q000378:metabolism*; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology*
D000947:Antigens, Helminth; D015848:Interleukin-5; D012333:RNA, Messenger; D003208:Concanavalin A; D014660:Vasoactive Intestinal Peptide